Literature DB >> 9108030

ELL2, a new member of an ELL family of RNA polymerase II elongation factors.

A Shilatifard1, D R Duan, D Haque, C Florence, W H Schubach, J W Conaway, R C Conaway.   

Abstract

We recently isolated an RNA polymerase II elongation factor from rat liver nuclei and found it to be homologous to the product of the human ELL gene, a frequent target for translocations in acute myeloid leukemia. To further our understanding of the possible role(s) of ELL in transcriptional regulation and human disease, we initiated a search for ELL-related proteins. In this report we describe molecular cloning, expression, and characterization of human ELL2, a novel RNA polymerase II elongation factor 49% identical and 66% similar to ELL. Mechanistic studies indicate that ELL2 and ELL possess similar transcriptional activities. Structure-function studies localize the ELL2 elongation activation domain to an ELL2 N-terminal region that is highly homologous to ELL. Finally, Northern blot analysis reveals that the ELL2 and ELL genes are transcribed in many of the same tissues, but that the ratio of their transcripts exhibits tissue-to-tissue variation, raising the possibility that ELL2 and ELL may not perform completely general functions, but, instead, may perform gene- or tissue-specific functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108030      PMCID: PMC20493          DOI: 10.1073/pnas.94.8.3639

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Regulation of transcriptional elongation by RNA polymerase II.

Authors:  D L Bentley
Journal:  Curr Opin Genet Dev       Date:  1995-04       Impact factor: 5.578

Review 2.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

3.  Purification of P-TEFb, a transcription factor required for the transition into productive elongation.

Authors:  N F Marshall; D H Price
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

4.  Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.

Authors:  M J Thirman; D A Levitan; H Kobayashi; M C Simon; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukemia with t(11;19)(q23;p13.1) translocation.

Authors:  K Mitani; Y Kanda; S Ogawa; T Tanaka; J Inazawa; Y Yazaki; H Hirai
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

6.  Stimulation of RNA polymerase II elongation by chromosomal protein HMG-14.

Authors:  H F Ding; S Rimsky; S C Batson; M Bustin; U Hansen
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

7.  Cloning and characterization of hdlg: the human homologue of the Drosophila discs large tumor suppressor binds to protein 4.1.

Authors:  R A Lue; S M Marfatia; D Branton; A H Chishti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  Inhibition of transcription elongation by the VHL tumor suppressor protein.

Authors:  D R Duan; A Pause; W H Burgess; T Aso; D Y Chen; K P Garrett; R C Conaway; J W Conaway; W M Linehan; R D Klausner
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

9.  Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein.

Authors:  L A Jesaitis; D A Goodenough
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

10.  Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions.

Authors:  M Furuse; M Itoh; T Hirase; A Nagafuchi; S Yonemura; S Tsukita; S Tsukita
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  57 in total

Review 1.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

Review 2.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

3.  Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Authors:  Man Mohan; Chengqi Lin; Erin Guest; Ali Shilatifard
Journal:  Nat Rev Cancer       Date:  2010-09-16       Impact factor: 60.716

4.  The eleven-nineteen lysine-rich leukemia gene (ELL2) influences the histone H3 protein modifications accompanying the shift to secretory immunoglobulin heavy chain mRNA production.

Authors:  Christine Milcarek; Michael Albring; Creityeka Langer; Kyung Soo Park
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

5.  A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency.

Authors:  Zichong Li; Huasong Lu; Qiang Zhou
Journal:  Mol Cell Biol       Date:  2016-02-01       Impact factor: 4.272

Review 6.  From B cell to plasma cell: regulation of V(D)J recombination and antibody secretion.

Authors:  Lisa Borghesi; Christine Milcarek
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

Authors:  Nanhai He; Min Liu; Joanne Hsu; Yuhua Xue; Seemay Chou; Alma Burlingame; Nevan J Krogan; Tom Alber; Qiang Zhou
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

8.  Mutational analysis of an RNA polymerase II elongation factor in Drosophila melanogaster.

Authors:  Mark A Gerber; Ali Shilatifard; Joel C Eissenberg
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.

Authors:  W Xiao; Q Zhang; G Habermacher; X Yang; A-Y Zhang; X Cai; J Hahn; J Liu; M Pins; L Doglio; R Dhir; J Gingrich; Z Wang
Journal:  Oncogene       Date:  2007-09-17       Impact factor: 9.867

10.  Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.

Authors:  Jiangang Zhou; Xi Feng; Bin Ban; Jingxia Liu; Zhou Wang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.